GOUT FLARE
Clinical trials for GOUT FLARE explained in plain language.
Never miss a new study
Get alerted when new GOUT FLARE trials appear
Sign up with your email to follow new studies for GOUT FLARE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hospital care comes home: could your living room replace a hospital bed?
Disease control Recruiting nowThis study is testing whether adults with sudden illnesses like infections, heart failure, or COPD can be safely treated at home instead of in a hospital. Researchers will compare costs, patient experience, and health outcomes for 3,000 participants who receive hospital-level car…
Matched conditions: GOUT FLARE
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New gout pill aims to stop flare pain in 3 days
Symptom relief Recruiting nowThis study tests whether dapansutrile tablets can reduce joint pain from an acute gout flare better than a placebo. About 300 adults with confirmed gout will take the drug or a dummy pill for 7 days. The main goal is to see if pain drops significantly within 72 hours of the first…
Matched conditions: GOUT FLARE
Phase: PHASE2, PHASE3 • Sponsor: Olatec Therapeutics LLC • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New gel injection aims to tame gout flare pain in days
Symptom relief Recruiting nowThis study tests whether a single injection of Purified Cortrophin Gel can safely reduce pain from an acute gout flare. About 150 adults with gout will receive either a 40-unit or 80-unit dose and report their pain levels over the next week. The goal is to find the best dose for …
Matched conditions: GOUT FLARE
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New gout drug aims to beat pain faster than standard treatment
Symptom relief Recruiting nowThis Phase 2 trial tests an experimental drug called ABP-745 against colchicine (a standard gout medicine) and a placebo in 380 adults with acute gout flares. The goal is to see if ABP-745 reduces pain and swelling better than current options. Participants will take tablets and r…
Matched conditions: GOUT FLARE
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC